Imagen de Portada

Coronary microvascular disease in heart failure with preserved ejection fraction

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Payel Sen, Lili Wang, Laura d'Ambrosio, Susanne Bierschenk, Jules Hamers, Irem Ornek, Theresa Sittig, Hengliang Zhang, Junqing Zhang, Daphne Merkus
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Physiological Reports
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Comment on: Malnutrition in heart failure with preserved ejection fraction
por: Conrad May
Publicado: (2024)

Reply to: Comment on: Malnutrition in heart failure with preserved ejection fraction
por: Ellen Brinza, et al.
Publicado: (2024)

Treatment of heart failure with preserved ejection fraction. A systematic review
por: WALTER GABRIEL CHAVES-SANTIAGO
Publicado: (2022)

The keto cure? Exploring ketogenic diet in heart failure with preserved ejection fraction
por: Bagus Aditya Ansharullah, et al.
Publicado: (2025)

Exercise‐induced arterial hypoxaemia in patients with heart failure with preserved ejection fraction
por: Michael G. Leahy, et al.
Publicado: (2025)

Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity
por: Ayesha Rehman, et al.
Publicado: (2024)

Vascular remodelling in a mouse model of heart failure with preserved ejection fraction
por: Fernanda Sanhueza‐Olivares, et al.
Publicado: (2025)

Strain‐based characterization of atrioventricular and left atrial remodelling in rat models of heart failure with preserved ejection fraction
por: Qingfeng Zhang, et al.
Publicado: (2026)

Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes
por: Takefumi Kishimori, et al.
Publicado: (2026)

ALPK2 prevents cardiac diastolic dysfunction in heart failure with preserved ejection fraction
por: Tatsuya Yoshida, et al.
Publicado: (2024)

Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models
por: Oana Sorop, et al.
Publicado: (2025)

Evaluation of renal sodium handling in heart failure with preserved ejection fraction: A pilot study
por: Adhish Agarwal, et al.
Publicado: (2024)

Adipose‐derived small extracellular vesicles exacerbate microvascular dysfunction in heart failure with preserved ejection fraction via mmu‐miR‐582‐3p‐mediated Rap1b suppression
por: Lu Chen, et al.
Publicado: (2026)

Improving therapeutic outcomes in heart failure with reduced nonvalvular ejection fraction: A clinical study of heart failure education intervention
por: Xueli Tian, et al.
Publicado: (2024)

Body composition in patients with obesity‐related heart failure with preserved ejection fraction: A comparison study
por: Hannah Salmons, et al.
Publicado: (2025)

A new sympathetic understanding of exercise blood flow regulation in heart failure with preserved ejection fraction
por: Giorgio Manferdelli, et al.
Publicado: (2024)

Evaluation of aldosterone antagonist utilization in heart failure with reduced and preserved ejection fraction at an academic medical center
por: Daniel Bradley
Publicado: (2019)

ExploitWP2Docker: a Platform for Automating the Generation of Vulnerable WordPress Environments for Cyber Ranges
por: Caturano, Francesco, et al.
Publicado: (2022)

Tirzepatide shown to improve clinical outcomes for patients with heart failure with preserved ejection fraction (HFpEF) and obesity
por: Iskandar Idris
Publicado: (2024)

Dual ETA‐ETB receptor antagonism improves metabolic syndrome‐induced heart failure with preserved ejection fraction
por: Francesca Lockwood, et al.
Publicado: (2025)

Comparative effectiveness of pharmacotherapy for heart failure with preserved ejection fraction: A systematic review and network meta‐analysis
por: Szu‐Han Chen, et al.
Publicado: (2026)

Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential
por: Zhongwen Qi, et al.
Publicado: (2025)

Phenotyping of acute heart failure with preserved ejection fraction: real‐world outcomes in a cohort of older patients
por: Maria Livia Burzo, et al.
Publicado: (2026)

α‐Adrenergic regulation of skeletal muscle blood flow during exercise in patients with heart failure with preserved ejection fraction
por: Jeremy K. Alpenglow, et al.
Publicado: (2024)

Breathless but unchanged: Exercise‐induced arterial hypoxaemia shows limited impact in patients with heart failure with preserved ejection fraction
por: Jeff Jiefu Liu, et al.
Publicado: (2025)

Distinguishing pathophysiological features of heart failure with reduced and preserved ejection fraction: A comparative analysis of two mouse models
por: Abraham Méndez‐Fernández, et al.
Publicado: (2024)

HBI‐8000 improves heart failure with preserved ejection fraction via the TGF‐β1/MAPK signalling pathway
por: Jing Tian, et al.
Publicado: (2024)

Hypertension and obesity independently drive hypertrophy and alter mitochondrial metabolism in a mouse model of heart failure with preserved ejection fraction
por: Benjamin Werbner, et al.
Publicado: (2024)

Is sinus rhythm maintenance after repeat catheter ablation effective in patients with atrial fibrillation and heart failure with preserved ejection fraction?
por: Yasuyuki Egami, et al.
Publicado: (2024)

Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING‐HF trial
por: Patricia Palau, et al.
Publicado: (2024)

The value of the HFA‐PEFF and H2FPEF scores in determining the phenotypes and comorbidity burden in heart failure with preserved ejection fraction
por: Selda Murat, et al.
Publicado: (2025)

PINK1 modulates Prdx2 to reduce lipotoxicity‐induced apoptosis and attenuate cardiac dysfunction in heart failure mice with a preserved ejection fraction
por: Hao Zhang, et al.
Publicado: (2025)

Practical considerations for the use of vericiguat in older patients with heart failure and reduced ejection fraction
por: Francesco Castelletti, et al.
Publicado: (2026)

Epidemiological and clinical characterization of patients hospitalized for decompensated heart failure with reduced ejection fraction
por: Laura Catalina Arcos-Medina
Publicado: (2020)

Förderung von heterogenen Zielgruppen im Übergang Schule – Beruf
por: Sittig, Melanie
Publicado: (2025)

Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: An exploratory study
por: Xiao‐Dong Zhou, et al.
Publicado: (2024)

Renal function trajectories in 'De Novo' heart failure with reduced ejection fraction: impact on outcomes
por: Otero-García, O., et al.
Publicado: (2026)

Current treatment for heart failure with reduced ejection fraction. A systematic review of the new therapies
por: JAIRO ALFONSO GÁNDARA-RICARDO
Publicado: (2021)

Oyun ve Gerçeklik
por: Örnek, Hakan
Publicado: (2024)

Association Between the Red Cell Distribution Width‐to‐Albumin Ratio and Pediatric Community‐Acquired Pneumonia
por: Zühal Örnek
Publicado: (2026)